spektrum der augenheilkunde - 150 Jahre Augenklinik Graz

originalarbeitunter der Leitung von Prof. Dr. Gerald Langmann undinsbesondere auch Dr. Werner Wackernagel.InteressenkonfliktDer korrespondierende Autor gibt für sich und seineKoautoren an, dass kein Interessenskonflikt besteht.Literatur1. Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, BreuningerH, Metzler G, et al. The incidence and mortality ofcutaneous melanoma in Southern Germany: trends byanatomic site and pathologic characteristics, 1976–2003.Cancer. 2006;107(6):1331–9 (Epub 2006/08/16).2. Demierre MF. Epidemiology and prevention of cutaneousmelanoma. Curr Treat Options Oncol. 2006;7(3):181–6(Epub 2006/04/18).3. Singh P, Singh A. Choroidal melanoma. Oman J Ophthalmol.2012;5(1):3–9 (Epub 2012/05/05).4. Shields CL, Shields JA, Kiratli H, De Potter P, Cater JR. Riskfactors for growth and metastasis of small choroidal melanocyticlesions. Ophthalmol. 1995;102(9):1351–61 (Epub1995/09/01).5. Augsburger JJ, Correa ZM, Trichopoulos N. An alternativehypothesis for observed mortality rates due to metastasisafter treatment of choroidal melanomas of different sizes.Trans Am Ophthalmol Soc. 2007;105:54–9; (discussion 9–60Epub 2008/04/23).6. Zielonke N. Krebsinzidenz und Krebsmortalität in Österreich.Österreich SABS, editor: MDH-Media GesmbH;2012.7. Singh AD, Kalyani P, Topham A. Estimating the risk of malignanttransformation of a choroidal nevus. Ophthalmol.2005;112(10):1784–9 (Epub 2005/09/13).8. Gass JD. Problems in the differential diagnosis of choroidalnevi and malignant melanomas. The XXXIII Edward JacksonMemorial Lecture. Am J Ophthalmol. 1977;83(3):299–323 (Epub 1977/03/01).9. Augsburger JJ, Correa ZM, Trichopoulos N, Shaikh A. Sizeoverlap between benign melanocytic choroidal nevi andchoroidal malignant melanomas. Invest Ophthalmol VisSci. 2008;49(7):2823–8 (Epub 2008/04/15).10. Singh AD, Schachat AP, Diener-West M, Reynolds SM. Smallchoroidal melanoma. Ophthalmol. 2008;115(12):2319.e3(Epub 2008/12/02).11. Group COMS. Mortality in patients with small choroidalmelanoma. COMS report no. 4. The CollaborativeOcular Melanoma Study Group. Arch Ophthalmol.1997;115(7):886–93 (Epub 1997/07/01).12. Shields CL, Cater J, Shields JA, Singh AD, Santos MC,Carvalho C. Combination of clinical factors predictive ofgrowth of small choroidal melanocytic tumors. Arch Ophthalmol.2000;118(3):360–4 (Epub 2000/03/18).13. Sahel JA, Pesavento R, Frederick AR, Jr., Albert DM.Melanoma arising de novo over a 16-month period. ArchOphthalmol. 1988;106(3):381–5 (Epub 1988/03/01).14. Wackernagel W, Schmutzer M, Mayer C, Jetzl J, LangmannA, Kleinert R, et al. Biopsie intraokularer Tumorebei klinisch unsicherer Diagnose. Spektrum Augeheilkd.2005;19(3):171–4.15. Mashayekhi A, Siu S, Shields CL, Shields JA. Slow enlargementof choroidal nevi: a long-term follow-up study. Ophthalmol.2011;118(2):382–8 (Epub 2010/08/31).16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, CondeJG. Research electronic data capture (REDCap)–a metadata-drivenmethodology and workflow process for providingtranslational research informatics support. J BiomedInform. 2009;42(2):377–81 (Epub 2008/10/22).17. Cook SA, Damato B, Marshall E, Salmon P. Reconciling theprinciple of patient autonomy with the practice of informedconsent: decision-making about prognostication inuveal melanoma. Health Expect. 2011;14(4):383–96.18. Wackernagel W, Schneider M, Mayer C, Langmann G,Singh AD. Genetik des Aderhautmelanoms. SpektrumAugeheilkd. 2009;23(5):319–32.19. van den Bosch T, van Beek, Paridaens D, et al. Higherpercentage of FISH-determined monosomy 3 and 8qamplification in uveal melanoma cells relate to poorpatient prognosis. Investigative Ophthalmol Vis Sci.2012;53(6):2668–74 (Epub 2012/03/20).20. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA,Campbell I, et al. Cytogenetics of uveal melanoma: a 7-yearclinical experience. Ophthalmol. 2007;114(10):1925–31(Epub 2007/08/28).304 PROCHORN – Prospektives Register von Patientinnen mit Aderhautnävi 1 3